CID 154700101

Irbesartan metabolite 4

Structural Information

Molecular Formula
C25H28N6O2
SMILES
CC(CCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5)O
InChI
InChI=1S/C25H28N6O2/c1-17(32)8-13-22-26-25(14-4-5-15-25)24(33)31(22)16-18-9-11-19(12-10-18)20-6-2-3-7-21(20)23-27-29-30-28-23/h2-3,6-7,9-12,17,32H,4-5,8,13-16H2,1H3,(H,27,28,29,30)
InChIKey
YASLDPAAWWZGIP-UHFFFAOYSA-N
Compound name
2-(3-hydroxybutyl)-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
Related CIDs

2D Structure

compound 2d structure
2
Annotation Hits

0
References

0
Patents

444.2274 Da
Monoisotopic Mass

2.8
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 445.234676 204.1
[M+Na]+ 467.216618 209.8
[M-H]- 443.220124 210.3
[M+NH4]+ 462.261223 210.5
[M+K]+ 483.190558 202.6
[M+H-H2O]+ 427.224660 191.7
[M+HCOO]- 489.225601 215.5
[M+CH3COO]- 503.241251 210.4
[M+Na-2H]- 465.202066 197.9
[M]+ 444.22685142 201.3
[M]- 444.22794858 201.3
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.